Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,505.00
+20.00 (0.45%)
At close: Aug 8, 2025, 3:30 PM KST
0.45%
Market Cap68.82B
Revenue (ttm)196.46B
Net Income (ttm)-3.08B
Shares Out15.33M
EPS (ttm)-205.41
PE Ration/a
Forward PEn/a
Dividend75.00 (1.67%)
Ex-Dividend DateDec 27, 2024
Volume42,901
Average Volume86,453
Open4,485.00
Previous Close4,485.00
Day's Range4,485.00 - 4,545.00
52-Week Range3,070.00 - 6,130.00
Beta0.68
RSI50.55
Earnings Daten/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.